Related references
Note: Only part of the references are listed.A phase 1, single centre, open label, escalating dose study to assess the safety, tolerability and immunogenicity of a therapeutic human papillomavirus (HPV) DNA vaccine (AMV002) for HPV-associated head and neck cancer (HNC)
J. Chandra et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010-2019
Laia Bruni et al.
PREVENTIVE MEDICINE (2021)
Sex- and Type-specific Genital Human Papillomavirus Transmission Rates Between Heterosexual Partners: A Bayesian Reanalysis of the HITCH Cohort
Talia Malagon et al.
EPIDEMIOLOGY (2021)
TLR Agonists as Mediators of Trained Immunity: Mechanistic Insight and Immunotherapeutic Potential to Combat Infection
Allison M. Owen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Male Circumcision Reduces Penile HPV Incidence and Persistence: A Randomized Controlled Trial in Kenya
Jennifer S. Smith et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)
Barriers towards HPV Vaccinations for Boys and Young Men: A Narrative Review
Maria Grandahl et al.
VIRUSES-BASEL (2021)
Immune checkpoints in the tumor microenvironment
Salman M. Toor et al.
SEMINARS IN CANCER BIOLOGY (2020)
Human Papillomavirus Vaccination for Adults Updated Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Lauren D. Oshman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
Asmita Pal et al.
FRONTIERS IN MICROBIOLOGY (2020)
The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease
Anna Rosa Garbuglia et al.
FRONTIERS IN IMMUNOLOGY (2020)
Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied
Simopekka Vanska et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Prevalence of human papillomavirus and subtype distribution in male partners of women with cervical intraepithelial neoplasia (CIN): a systematic review
Anargyros Skoulakis et al.
BMC INFECTIOUS DISEASES (2019)
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Hyun Cheol Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial
R. Wendel Naumann et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Eradication of human papillomavirus and elimination of HPV-related diseases - scientific basis for global public health policies
Matti Lehtinen et al.
EXPERT REVIEW OF VACCINES (2019)
Does Male Circumcision Reduce Women's Risk of Sexually Transmitted Infections, Cervical Cancer, and Associated Conditions?
Brian J. Morris et al.
FRONTIERS IN PUBLIC HEALTH (2019)
Impact of gender-neutral or girls-only vaccination against human papillomavirus-Results of a community-randomized clinical trial (I)
Matti Lehtinen et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Epidemiology and burden of HPV-related disease
Beatriz Serrano et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2018)
Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma
Dana Holzinger et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Worldwide burden of cancer attributable to HPV by site, country and HPV type
Catherine de Martel et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection
Anna R. Giuliano et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A prospective analysis of smoking and human papillomavirus infection among men in the HPV in Men Study
Matthew B. Schabath et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The impact of smoking on HPV infection and the development of anogenital warts
Reto Kaderli et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2014)
TLR agonists as modulators of the innate immune response and their potential as agents against infectious disease
Edin J. Mifsud et al.
FRONTIERS IN IMMUNOLOGY (2014)
Smoking and Human Papillomavirus (HPV) Infection in the HPV in Men (HIM) Study
Matthew B. Schabath et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease
Marc Arbyn et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Male Human Papillomavirus Prevalence and Association With Condom Use in Brazil, Mexico, and the United States
Kimberly K. Repp et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Prevalence of DNA-HPV in Male Sexual Partners of HPV-Infected Women and Concordance of Viral Types in Infected Couples
Maria Gabrielle de Lima Rocha et al.
PLOS ONE (2012)
Incidence of human papillomavirus infection in male sexual partners of women diagnosed with CIN II-III
Gemma Martin-Ezquerra et al.
EUROPEAN JOURNAL OF DERMATOLOGY (2012)
External Genital Human Papillomavirus Prevalence and Associated Factors Among Heterosexual Men on 5 Continents
Eftyhia Vardas et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Human Papillomavirus Infections Among Couples in New Sexual Relationships
Ann N. Burchell et al.
EPIDEMIOLOGY (2010)
Human papillomavirus found in sperm head of young adult males affects the progressive motility
Carlo Foresta et al.
FERTILITY AND STERILITY (2010)
Male Circumcision Decreases Acquisition and Increases Clearance of High-Risk Human Papillomavirus in HIV-Negative Men: A Randomized Trial in Rakai, Uganda
Ronald H. Gray et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Factors Associated with Acquisition and Clearance of Human Papillomavirus Infection in a Cohort of US Men: A Prospective Study
Beibei Lu et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Risk factors for anogenital human papillomavirus infection in men
Carrie M. Nielson et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: The HPV detection in men study
Anna R. Giuliano et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Human papillomavirus prevalence and type distribution in male anogenital sites and semen
Carrie M. Nielson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Concordance of specific human papillomavirus types in sex partners is more prevalent than would be expected by chance and is associated with increased viral loads
MCG Bleeker et al.
CLINICAL INFECTIOUS DISEASES (2005)
Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection
SM Nicolau et al.
UROLOGY (2005)
Condom use and other factors affecting penile human papillomavirus detection in men attending a sexually transmitted disease clinic
SB Baldwin et al.
SEXUALLY TRANSMITTED DISEASES (2004)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Human papillomavirus and cervical cancer
EM Burd
CLINICAL MICROBIOLOGY REVIEWS (2003)
Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinic
EI Svare et al.
SEXUALLY TRANSMITTED INFECTIONS (2002)
Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners.
X Castellsague et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream
TL Schroeder et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Share Paper
